🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase III trial compares the effect of adding sonrotoclax to zanubruti...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2026-04-30
Trial ID
NCT07321652
This study is a prospective, multicenter, open-label, single-arm phase II c...
Status
Recruiting
Location
Jiangsu Province Hospital
Start Date
2026-06-01
Trial ID
NCT07671378
Treatments Being Tested
This is a single-arm, open-label study of sonrotoclax plus zanubrutinib wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-30
Trial ID
NCT06367374
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability; and to ...
Status
Active Not Recruiting
Location
UCLA Hematologyoncology
Start Date
2020-03-24
Trial ID
NCT04277637
Treatments Being Tested
This phase II trial studies the side effects of an escalated ramp-up of son...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-06-02
Trial ID
NCT06839053
A Single-Arm, Prospective Clinical Study Evaluating the Efficacy and Safety...
Status
Not Yet Recruiting
Location
Shanghai Ruijin Hospital
Start Date
2026-04-20
Trial ID
NCT07548255
Treatments Being Tested
The purpose of this study is to evaluate the relative bioavailability of a ...
Status
Completed
Location
Linear Early Phase
Start Date
2025-09-24
Trial ID
NCT07141511
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of fixe...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2026-01-22
Trial ID
NCT07277231
Treatments Being Tested
The purpose of this study is to measure the safety, preliminary antitumor a...
Status
Recruiting
Location
Mayo Clinic Phoenix
Start Date
2024-11-27
Trial ID
NCT06634589
Treatments Being Tested
This phase I trial tests zanubrutinib in combination with sonrotoclax for t...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-08-25
Trial ID
NCT06859008